The National Cancer Society Malaysia has issued an urgent call for a coordinated national screening framework to combat the accelerating threat of cardio-renal-metabolic diseases, which encompass heart conditions, kidney disease and metabolic disorders such as diabetes. The organisation's appeal signals growing alarm over the interconnected nature of these conditions, which increasingly coexist in Malaysian patients and compound each other's health impacts. With nearly nine in every ten individuals identified as carrying two or more risk factors for these diseases, the health system faces mounting pressure to rethink its approach to chronic disease management.
The gravity of the situation became apparent following a screening initiative that enrolled 5,000 participants from economically disadvantaged areas across the Klang Valley. The Saring@Komuniti Project, conducted jointly by NCSM and pharmaceutical company Boehringer Ingelheim with Ministry of Health backing, revealed a sobering picture of hidden disease burden within these communities. The data underscores a critical gap in current detection and prevention efforts, particularly among populations least equipped to manage complex health conditions independently. The project's findings have prompted NCSM to formulate detailed policy recommendations and launch policy briefs specifically designed to guide national action on this issue.
The screening results paint a stark portrait of metabolic dysfunction and obesity within Malaysia's population. More than four in ten participants fell into the obese category, while a further 28.8 per cent were classified as overweight, creating a substantial pool of individuals at heightened cardiovascular and metabolic risk. Blood sugar control emerged as a particularly acute concern, with 34.5 per cent exhibiting pre-diabetic markers and 35.1 per cent already diagnosed with diabetes. The near-universal prevalence of at least one CRM risk factor among 97.8 per cent of screened individuals indicates that preventable disease burden has become the norm rather than the exception in affected communities. These figures reveal the extent to which preventive healthcare infrastructure has failed to catch disease at earlier, more manageable stages.
The Malaysian health crisis represents a tangible and measurable escalation in recent years. Chronic kidney disease prevalence has nearly doubled from 9.1 per cent in 2011 to 15.5 per cent by 2019, signalling a deteriorating national kidney health picture. The explosion in demand for dialysis services, which has more than tripled over the past two decades, demonstrates the downstream consequences of late diagnosis and inadequate disease management. These trends suggest that without substantial systemic changes, healthcare facilities will face unsustainable resource demands while patient outcomes continue to deteriorate. The financial and human costs of managing advanced kidney disease through dialysis vastly exceed the costs of earlier detection and preventive intervention.
Current healthcare delivery in Malaysia is structurally ill-equipped to address the interconnected nature of these conditions. The system typically manages cardiovascular disease, kidney disease and metabolic disorders as separate clinical entities, resulting in fragmented assessment and treatment. This siloed approach creates dangerous blind spots, where clinicians addressing one condition may fail to recognize or act upon simultaneous risks in other systems. Patients frequently navigate disconnected referral pathways, encounter inconsistent follow-up protocols, and face barriers that prevent continuous engagement with the healthcare system after abnormal screening results. The consequence is a revolving door effect where identification of disease occurs but meaningful intervention and sustained management falter.
NCSM's policy recommendations articulate two foundational priorities for systemic reform. The first involves expanding integrated co-screening programmes to enable earlier simultaneous detection of interconnected diseases, preventing the current situation where disease identification occurs piecemeal and late. The second priority demands strengthening the complete care pathway, ensuring that individuals smoothly transition from initial screening through diagnosis, active treatment and sustained long-term management. These complementary strategies acknowledge that detection alone provides no benefit if the system cannot ensure subsequent appropriate intervention and follow-up. The recommendations include embedding standardized CRM risk assessments into routine health checks, scaling screening programmes across the country, and establishing robust referral and follow-up mechanisms.
Dr Murallitharan Munisamy, Managing Director of NCSM, emphasised that Malaysia stands at a critical juncture where fundamental healthcare philosophy must shift. Rather than treating cardiovascular, kidney and metabolic health as separate domains, the nation must recognize and address them as components of an integrated continuum. This conceptual reframing has profound implications for clinical training, health service organization, resource allocation and public health messaging. Early detection, while necessary, remains insufficient without matched investment in coordinated follow-up and durable management systems that sustain patient engagement over years. The current trajectory of rising disease burden and healthcare costs cannot be arrested through detection alone; transformation requires systematic integration across the entire care pathway.
Boehringer Ingelheim Malaysia's General Manager and Head of Human Pharma, Cheong Yee Kok, reinforced this perspective by highlighting the biological reality that cardiovascular, kidney and metabolic conditions share common underlying pathways. These conditions amplify each other's impact, creating multiplicative rather than additive disease burden. Understanding this interconnectedness is essential for healthcare providers designing interventions, policymakers allocating resources and individuals managing their own health. The implications extend beyond clinical practice into public health messaging, which must communicate that managing one risk factor in isolation may prove insufficient if other interconnected risks remain unaddressed.
The timing of NCSM's policy push coincides with Malaysia's continued struggle against escalating chronic disease prevalence. The nation's healthcare system already operates under substantial strain managing current disease burden; without preventive intervention and systems integration, this burden will accelerate further. International experience demonstrates that integrated screening and care coordination approaches yield superior outcomes at lower cost compared to fragmented systems managing diseases individually. Neighbouring countries and regional peers have begun implementing similar integrated approaches, creating opportunities for Malaysia to learn from emerging evidence about effective implementation strategies.
Implementing the recommended national screening strategy will require substantial coordination across multiple healthcare levels and between government and private sectors. Primary care facilities will need standardised assessment tools and training to identify CRM risk profiles comprehensively. Secondary and tertiary facilities must establish clear protocols for receiving, investigating and managing referrals from community screening. Information systems must enable data sharing and tracking of individual patient pathways through the care continuum. Public health campaigns will need to communicate the importance of screening and emphasize the interconnected nature of these risks. Investment in health workforce training will be essential, particularly for primary care providers who will conduct initial screening and coordinate ongoing management.
The sustainability of any national screening strategy ultimately depends on establishing systems that patients can access affordably and navigate successfully. Particular attention must be given to ensuring that screening programmes reach underserved communities where disease burden is highest and access barriers most substantial. Many Malaysians lack regular engagement with primary healthcare, making opportunistic screening during other health encounters critical. Overcoming challenges of cost, geographic accessibility, health literacy and continuity of care will determine whether a screening strategy translates into meaningful improvements in health outcomes. The Klang Valley project demonstrates feasibility of reaching at-risk populations; scaling this approach nationally while maintaining quality and ensuring follow-up represents the next critical challenge.
Malaysia's health system stands at an inflection point regarding chronic disease management philosophy and practice. The evidence from the Saring@Komuniti Project and the escalating prevalence trends provide compelling justification for systemic change. NCSM's call for an integrated national co-screening strategy offers a concrete framework for addressing interconnected cardiorenal-metabolic diseases more effectively than current fragmented approaches. Success requires sustained political commitment, adequate resource allocation, health workforce development and sustained coordination across sectoral boundaries. The alternative—continuing with current disease management approaches—will result in preventable suffering, premature mortality and unsustainable healthcare expenditure. For Malaysian policymakers, the choice between system transformation and incremental decline has become increasingly urgent.
